Hyperlipidemia due to hepatic triglyceride lipase deficiency

MONDO:0013533

Hyperlipidemia due to hepatic triacylglycerol lipase deficiency is a rare, genetic hyperalphalipoproteinemia characterized by elevated plasma cholesterol and triglyceride (TG) levels with a marked TG enrichment of low- and high-density lipoproteins (HDL), presence of circulating beta-very low density lipoproteins and elevated HDL cholesterol levels, in the presence of a very low, or undetectable, postheparin plasma hepatic lipase activity. Premature atherosclerosis and/or coronary heart disease may be associated.

Also known as: hyperlipidemia due to HL deficiency, hyperlipidemia due to HTGL deficiency, hyperlipidemia due to hepatic lipase deficiency, HL deficiency, hepatic lipase deficiency, hyperlipidemia due to hepatic triacylglycerol lipase deficiency, lipc deficiency

35 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by